MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer

The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer

(2013) Dabei Tang et al.   CLINICAL BIOCHEMISTRY

MicroRNA-16 affects key functions of human endothelial progenitor cells

(2013) Emeline Goretti et al.   JOURNAL OF LEUKOCYTE BIOLOGY

miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma

(2012) CHENG-KUI CAI et al.   ONCOLOGY REPORTS

miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors

(2012) Marina Gonçalves Diniz et al.   CELLULAR ONCOLOGY

Src: a potential target for the treatment of triple-negative breast cancer

(2011) D. Tryfonopoulos et al.   ANNALS OF ONCOLOGY

Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia

(2011) D. Sampath et al.   BLOOD

MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells

(2011) Syunsuke Noguchi et al.   CANCER LETTERS

MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer

(2011) W. Shi et al.   CANCER RESEARCH

Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer

(2011) M Musumeci et al.   ONCOGENE

Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy

(2009) Alessandro Sgambato et al.   CANCER SCIENCE

Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells

(2009) Jie Yang et al.   MEDICAL ONCOLOGY

Cyclin E deregulation is an early event in the development of breast cancer

(2008) Alexandra Shaye et al.   BREAST CANCER RESEARCH AND TREATMENT